Biomarkers

Discover all biomarkers in precision medicine

Loading biomarkers...

Prostate Specific Antigen - Biomarker

Results for "Prostate-specific antigen"

Target: Prostate-specific antigen

Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum

Clinical Applications

Prostate CancerNormalProstatitisBenign prostate hyperplasia

uniprot

Approved Therapies

LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE) ^[5]

Status: approved

APPROVED

Axumin (FLUCICLOVINE F-18) ^[6]

Status: approved

APPROVED

Gallium Ga-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE) ^[7]

Status: approved

APPROVED

Choline C 11 (CHOLINE C-11) ^[8]

Status: approved

APPROVED

POSLUMA (FLOTUFOLASTAT F-18) ^[9]

Status: approved

APPROVED

PYLARIFY (PIFLUFOLASTAT F-18) ^[10]

Status: approved

APPROVED

Pipeline Therapies

Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life

CHU de Quebec-Universite Laval

PHASE2

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

UNICANCER

PHASE2

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

NRG Oncology

PHASE2, PHASE3

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

Aragon Pharmaceuticals, Inc.

PHASE1

A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Janssen Research & Development, LLC

PHASE1

Companies Working on Prostate-specific antigen

CHU de Quebec-Universite Laval

Prostate Cancer

UNICANCER

Adenocarcinoma of Prostate

NRG Oncology

Stage I Prostate Adenocarcinoma AJCC v7

DocetaxelLeuprolideGoserelin

Aragon Pharmaceuticals, Inc.

Prostatic Neoplasms

PrednisoneAbiraterone Acetate

TrialsMap

Clinical Intelligence Agent

Interactive Clinical Trials Map

3847

United States

1364

Europe

815

Asia

550

Other

LitSearch

Scientific Literature Agent

Scientific Publications

Prostate specific antigen screening.

PubMedApr 2007

Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.

PubMedAug 2016

Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.

PubMedJul 2024

Prostate specific antigen testing.

PubMedJun 2004

Biosensing strategies for diagnosis of prostate specific antigen.

PubMedFeb 2022

Research Insights

Publication count:

5 papers

Research focus:

Prostate Cancer

Sources & References

Prostate specific antigen screening.

PubMed•Apr 2007

Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.

PubMed•Aug 2016

Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.

PubMed•Jul 2024

Prostate specific antigen testing.

PubMed•Jun 2004

Biosensing strategies for diagnosis of prostate specific antigen.

PubMed•Feb 2022

Biomarkers

Results for "Prostate-specific antigen"

Target: Prostate-specific antigen

Clinical Applications

Approved Therapies

LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE) [5]

Axumin (FLUCICLOVINE F-18) [6]

Gallium Ga-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE) [7]

Choline C 11 (CHOLINE C-11) [8]

POSLUMA (FLOTUFOLASTAT F-18) [9]

PYLARIFY (PIFLUFOLASTAT F-18) [10]

Pipeline Therapies

Effects of EPA on Prostate Cancer Cells Proliferation and Quality of Life

Comparison of HT Concomitant With RT vs RT Alone in Patients With a Detectable PSA After Prostatectomy

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer

A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate Cancer

Companies Working on Prostate-specific antigen

CHU de Quebec-Universite Laval

UNICANCER

NRG Oncology

Aragon Pharmaceuticals, Inc.

TrialsMap

Interactive Clinical Trials Map

LitSearch

Scientific Publications

Prostate specific antigen screening.

Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis.

Prostate-Specific Antigen Values in Transgender Women Receiving Estrogen.

Prostate specific antigen testing.

Biosensing strategies for diagnosis of prostate specific antigen.

Research Insights

Sources & References

LOCAMETZ (KIT FOR THE PREPARATION OF GALLIUM GA 68 GOZETOTIDE) ^[5]

Axumin (FLUCICLOVINE F-18) ^[6]

Gallium Ga-68 PSMA-11 (GALLIUM GA-68 GOZETOTIDE) ^[7]

Choline C 11 (CHOLINE C-11) ^[8]

POSLUMA (FLOTUFOLASTAT F-18) ^[9]

PYLARIFY (PIFLUFOLASTAT F-18) ^[10]